News Summary: Targeted cancer drug approved

News Summary: US regulators approve first-of-a-kind cancer drug that targets breast tumors

Associated Press

SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.

PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.

TUMOR TARGETING: The binding chemical keeps the cocktail intact until it hits a cancer cell, delivering a potent dose of anti-tumor poison.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You